Copyright Reports & Markets. All rights reserved.

Global Lacosamide Tablets Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lacosamide Tablets Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 50 mg/tablet
    • 1.3.3 100 mg/tablet
    • 1.3.4 150 mg/tablet
    • 1.3.5 200 mg/tablet
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lacosamide Tablets Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Adults
    • 1.4.3 Children
  • 1.5 Global Lacosamide Tablets Market Size & Forecast
    • 1.5.1 Global Lacosamide Tablets Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Lacosamide Tablets Sales Quantity (2021-2032)
    • 1.5.3 Global Lacosamide Tablets Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 UCB
    • 2.1.1 UCB Details
    • 2.1.2 UCB Major Business
    • 2.1.3 UCB Lacosamide Tablets Product and Services
    • 2.1.4 UCB Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 UCB Recent Developments/Updates
  • 2.2 Aesica Pharmaceuticals GmbH
    • 2.2.1 Aesica Pharmaceuticals GmbH Details
    • 2.2.2 Aesica Pharmaceuticals GmbH Major Business
    • 2.2.3 Aesica Pharmaceuticals GmbH Lacosamide Tablets Product and Services
    • 2.2.4 Aesica Pharmaceuticals GmbH Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Aesica Pharmaceuticals GmbH Recent Developments/Updates
  • 2.3 Teva
    • 2.3.1 Teva Details
    • 2.3.2 Teva Major Business
    • 2.3.3 Teva Lacosamide Tablets Product and Services
    • 2.3.4 Teva Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Teva Recent Developments/Updates
  • 2.4 MSN Laboratories
    • 2.4.1 MSN Laboratories Details
    • 2.4.2 MSN Laboratories Major Business
    • 2.4.3 MSN Laboratories Lacosamide Tablets Product and Services
    • 2.4.4 MSN Laboratories Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 MSN Laboratories Recent Developments/Updates
  • 2.5 Alembic Pharma
    • 2.5.1 Alembic Pharma Details
    • 2.5.2 Alembic Pharma Major Business
    • 2.5.3 Alembic Pharma Lacosamide Tablets Product and Services
    • 2.5.4 Alembic Pharma Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Alembic Pharma Recent Developments/Updates
  • 2.6 Glenmark
    • 2.6.1 Glenmark Details
    • 2.6.2 Glenmark Major Business
    • 2.6.3 Glenmark Lacosamide Tablets Product and Services
    • 2.6.4 Glenmark Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Glenmark Recent Developments/Updates
  • 2.7 Accord Healthcare
    • 2.7.1 Accord Healthcare Details
    • 2.7.2 Accord Healthcare Major Business
    • 2.7.3 Accord Healthcare Lacosamide Tablets Product and Services
    • 2.7.4 Accord Healthcare Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Accord Healthcare Recent Developments/Updates
  • 2.8 Mylan
    • 2.8.1 Mylan Details
    • 2.8.2 Mylan Major Business
    • 2.8.3 Mylan Lacosamide Tablets Product and Services
    • 2.8.4 Mylan Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Mylan Recent Developments/Updates
  • 2.9 Sun PharmaApotex
    • 2.9.1 Sun PharmaApotex Details
    • 2.9.2 Sun PharmaApotex Major Business
    • 2.9.3 Sun PharmaApotex Lacosamide Tablets Product and Services
    • 2.9.4 Sun PharmaApotex Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 Sun PharmaApotex Recent Developments/Updates
  • 2.10 Jiangxi Qingfeng Pharmaceutical
    • 2.10.1 Jiangxi Qingfeng Pharmaceutical Details
    • 2.10.2 Jiangxi Qingfeng Pharmaceutical Major Business
    • 2.10.3 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Product and Services
    • 2.10.4 Jiangxi Qingfeng Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Jiangxi Qingfeng Pharmaceutical Recent Developments/Updates
  • 2.11 Beijing Sihuan Pharmaceutical
    • 2.11.1 Beijing Sihuan Pharmaceutical Details
    • 2.11.2 Beijing Sihuan Pharmaceutical Major Business
    • 2.11.3 Beijing Sihuan Pharmaceutical Lacosamide Tablets Product and Services
    • 2.11.4 Beijing Sihuan Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 Beijing Sihuan Pharmaceutical Recent Developments/Updates
  • 2.12 Buchang Pharmaceutical
    • 2.12.1 Buchang Pharmaceutical Details
    • 2.12.2 Buchang Pharmaceutical Major Business
    • 2.12.3 Buchang Pharmaceutical Lacosamide Tablets Product and Services
    • 2.12.4 Buchang Pharmaceutical Lacosamide Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Buchang Pharmaceutical Recent Developments/Updates

3 Competitive Environment: Lacosamide Tablets by Manufacturer

  • 3.1 Global Lacosamide Tablets Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Lacosamide Tablets Revenue by Manufacturer (2021-2026)
  • 3.3 Global Lacosamide Tablets Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Lacosamide Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Lacosamide Tablets Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Lacosamide Tablets Manufacturer Market Share in 2025
  • 3.5 Lacosamide Tablets Market: Overall Company Footprint Analysis
    • 3.5.1 Lacosamide Tablets Market: Region Footprint
    • 3.5.2 Lacosamide Tablets Market: Company Product Type Footprint
    • 3.5.3 Lacosamide Tablets Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lacosamide Tablets Market Size by Region
    • 4.1.1 Global Lacosamide Tablets Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Lacosamide Tablets Consumption Value by Region (2021-2032)
    • 4.1.3 Global Lacosamide Tablets Average Price by Region (2021-2032)
  • 4.2 North America Lacosamide Tablets Consumption Value (2021-2032)
  • 4.3 Europe Lacosamide Tablets Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Lacosamide Tablets Consumption Value (2021-2032)
  • 4.5 South America Lacosamide Tablets Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Lacosamide Tablets Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 5.2 Global Lacosamide Tablets Consumption Value by Type (2021-2032)
  • 5.3 Global Lacosamide Tablets Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 6.2 Global Lacosamide Tablets Consumption Value by Application (2021-2032)
  • 6.3 Global Lacosamide Tablets Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 7.2 North America Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 7.3 North America Lacosamide Tablets Market Size by Country
    • 7.3.1 North America Lacosamide Tablets Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Lacosamide Tablets Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 8.2 Europe Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 8.3 Europe Lacosamide Tablets Market Size by Country
    • 8.3.1 Europe Lacosamide Tablets Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Lacosamide Tablets Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Lacosamide Tablets Market Size by Region
    • 9.3.1 Asia-Pacific Lacosamide Tablets Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Lacosamide Tablets Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 10.2 South America Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 10.3 South America Lacosamide Tablets Market Size by Country
    • 10.3.1 South America Lacosamide Tablets Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Lacosamide Tablets Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Lacosamide Tablets Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Lacosamide Tablets Market Size by Country
    • 11.3.1 Middle East & Africa Lacosamide Tablets Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Lacosamide Tablets Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Lacosamide Tablets Market Drivers
  • 12.2 Lacosamide Tablets Market Restraints
  • 12.3 Lacosamide Tablets Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lacosamide Tablets and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lacosamide Tablets
  • 13.3 Lacosamide Tablets Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lacosamide Tablets Typical Distributors
  • 14.3 Lacosamide Tablets Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global Lacosamide Tablets market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
    The lacosamide tablet is an antiepileptic drug that may be used as an add-on to other antiepileptic drugs ("complementary therapy") to treat focal seizures (seizures that start in one area of the brain).
    This report is a detailed and comprehensive analysis for global Lacosamide Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global Lacosamide Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lacosamide Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lacosamide Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
    Global Lacosamide Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for Lacosamide Tablets
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global Lacosamide Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include UCB, Aesica Pharmaceuticals GmbH, Teva, MSN Laboratories, Alembic Pharma, Glenmark, Accord Healthcare, Mylan, Sun PharmaApotex, Jiangxi Qingfeng Pharmaceutical, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market Segmentation
    Lacosamide Tablets market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    50 mg/tablet
    100 mg/tablet
    150 mg/tablet
    200 mg/tablet
    Market segment by Application
    Adults
    Children
    Major players covered
    UCB
    Aesica Pharmaceuticals GmbH
    Teva
    MSN Laboratories
    Alembic Pharma
    Glenmark
    Accord Healthcare
    Mylan
    Sun PharmaApotex
    Jiangxi Qingfeng Pharmaceutical
    Beijing Sihuan Pharmaceutical
    Buchang Pharmaceutical
    Market segment by region, regional analysis covers
    North America (United States, Canada, and Mexico)
    Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
    Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
    South America (Brazil, Argentina, Colombia, and Rest of South America)
    Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 15 chapters:
    Chapter 1, to describe Lacosamide Tablets product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top manufacturers of Lacosamide Tablets, with price, sales quantity, revenue, and global market share of Lacosamide Tablets from 2021 to 2026.
    Chapter 3, the Lacosamide Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
    Chapter 4, the Lacosamide Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
    Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lacosamide Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
    Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
    Chapter 13, the key raw materials and key suppliers, and industry chain of Lacosamide Tablets.
    Chapter 14 and 15, to describe Lacosamide Tablets sales channel, distributors, customers, research findings and conclusion.

    Buy now